Mark Ragosa is CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 19,086 shares of KNSA, which is worth approximately $769,547. The most recent transaction as insider was on Apr 26, 2022, when has been sold 282 shares (Class A Common Share) at a price of $9.99 per share, resulting in proceeds of $2,817. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.1K
38.6% 3M change
16.87% 12M change
Total Value Held $769,547

Mark Ragosa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 26 2022
SELL
Payment of exercise price or tax liability
$2,817 $9.99 p/Share
282 Reduced 4.25%
6,357 Class A Common Share
Apr 26 2022
BUY
Exercise of conversion of derivative security
-
991 Added 12.99%
6,639 Class A Common Share
Mar 21 2022
SELL
Payment of exercise price or tax liability
$11,496 $10.98 p/Share
1,047 Reduced 15.64%
5,648 Class A Common Share
Mar 21 2022
BUY
Exercise of conversion of derivative security
-
3,019 Added 31.08%
6,695 Class A Common Share
Mar 16 2022
SELL
Payment of exercise price or tax liability
$3,069 $10.13 p/Share
303 Reduced 7.61%
3,676 Class A Common Share
Mar 16 2022
BUY
Exercise of conversion of derivative security
-
872 Added 17.98%
3,979 Class A Common Share
Dec 31 2020
SELL
Payment of exercise price or tax liability
$22,918 $17.67 p/Share
1,297 Reduced 29.45%
3,107 Class A Common Share
Dec 31 2020
BUY
Exercise of conversion of derivative security
-
4,404 Added 50.0%
4,404 Class A Common Share
MR

Mark Ragosa

CHIEF FINANCIAL OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA